We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATAI icon
12251
PUT
AtaiBeckley Inc
ATAI
$2.69B
$55.3K ﹤0.01%
41,600
-8,700
-17% -$11.6K
GOEV
12252
CALL
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$55.2K ﹤0.01%
39,120
+18,857
+93% +$205K
EWL icon
12253
PUT
iShares MSCI Switzerland ETF
EWL
$2.21B
$55.2K ﹤0.01%
1,200
+600
+100% +$29.3K
GELS
12254
Gelteq Ltd
GELS
$6.21M
$55.1K ﹤0.01%
+23,748
New +$58K
AURA icon
12255
PUT
Aura Biosciences
AURA
$797M
$55.1K ﹤0.01%
6,700
+2,000
+43% +$18.8K
ADIL
12256
Adial Pharmaceuticals
ADIL
$10.5M
$55.1K ﹤0.01%
2,180
+849
+64% +$22.1K
HYMC icon
12257
CALL
Hycroft Mining Holding Corp
HYMC
$2.52B
$54.9K ﹤0.01%
24,840
-2,740
-10% -$6.48K
RJET
12258
CALL
Republic Airways Holdings
RJET
$952M
$54.9K ﹤0.01%
3,153
+2,053
+187% +$31.8K
XSOE icon
12259
CALL
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.12B
$54.9K ﹤0.01%
+1,800
New +$57.7K
DBB icon
12260
CALL
Invesco DB Base Metals Fund
DBB
$315M
$54.7K ﹤0.01%
2,900
-26,200
-90% -$531K
GIB icon
12261
PUT
CGI
GIB
$15.2B
$54.7K ﹤0.01%
500
-1,100
-69% -$124K
PBYI icon
12262
CALL
Puma Biotechnology
PBYI
$456M
$54.6K ﹤0.01%
17,900
-15,500
-46% -$45.1K
ANRO icon
12263
CALL
Alto Neuroscience
ANRO
$1.26B
$54.6K ﹤0.01%
12,900
-27,400
-68% -$171K
CIGI icon
12264
PUT
Colliers International
CIGI
$5.39B
$54.4K ﹤0.01%
400
-400
-50% -$59.1K
LUNA
12265
DELISTED
Luna Innovations Incorporated
LUNA
$54.3K ﹤0.01%
+25,129
New +$44.4K
TGB
12266
Trekor Metals
TGB
$3.06B
$54.3K ﹤0.01%
27,974
-61,030
-69% -$134K
WMK icon
12267
CALL
Weis Markets
WMK
$1.76B
$54.2K ﹤0.01%
800
-2,100
-72% -$145K
XAGE
12268
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
$54.1K ﹤0.01%
+6,252
New +$59.4K
DSL
12269
CALL
DoubleLine Income Solutions Fund
DSL
$1.24B
$54.1K ﹤0.01%
4,300
+2,900
+207% +$36.9K
FWRG icon
12270
PUT
First Watch Restaurant Group
FWRG
$785M
$54K ﹤0.01%
+2,900
New +$51.2K
XBIO icon
12271
Xenetic Biosciences
XBIO
$7.51M
$53.9K ﹤0.01%
+13,380
New +$54K
CMTG icon
12272
PUT
Claros Mortgage Trust
CMTG
$257M
$53.8K ﹤0.01%
11,900
+6,800
+133% +$42.4K
GLL icon
12273
ProShares UltraShort Gold
GLL
$104M
$53.7K ﹤0.01%
764
-1,058
-58% -$72.2K
NOMD icon
12274
CALL
Nomad Foods
NOMD
$1.64B
$53.7K ﹤0.01%
3,200
-11,300
-78% -$197K
TUSK icon
12275
Mammoth Energy Services
TUSK
$160M
$53.6K ﹤0.01%
17,865
-47,425
-73% -$175K

Similar funds

Ken Griffin's Q4 2024 Portfolio in Review

As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
  • Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.